Back

Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: treatment 1 Rhythm Control, Antiarrhythmic Drugs EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Andreas Rillig

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

7 More presentations in this session

Presentation thumbnail
Effectiveness of photoplethysmography-based rhythm monitoring after atrial fibrillation ablation using a smartphone application
Doctor H. Gruwez (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Predicting bleeding risk in frail older patients with atrial fibrillation using data from the FRAIL-AF trial
Doctor S. van Doorn (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Management of edoxaban therapy in patients undergoing emergency/urgent procedures: a subanalysis of the global, prospective, observational, multinational EMIT-AF/VTE programme
Professor C. Von Heymann (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Impact of different dose reduction criteria on dose assignment of current DOACs and related outcomes: an analysis from 4-year data of the ETNA-AF Europe programme
Assistant Professor I. Diemberger (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Difference between cryoballoon and radiofrequency ablations for atrial fibrillation based on electroanatomical mechanisms
Doctor M. Kim (Yongin, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: treatment 1

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Cluster-specific predictors of early rhythm control in contemporary European cohort of patients with atrial fibrillation: The EHRA-PATHS Project
thumbnail
Congress Presentation
Impact of rhythm control strategy on outcomes in patients with first diagnosed atrial fibrillation in an 11-year real-world registry
thumbnail
Congress Presentation
Early rhythm control in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources